NDC 68382-474-30 - Pramipexole Dihydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68382-474
- Requested NDC
- 68382-474-30
- Package NDCs from labels
- 68382-474-06, 68382-474-30, 68382-474-77
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2022-11-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PRAMIPEXOLE - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2022-11-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona Vital Line | HYDROLYZED COLLAGEN | ANUBIS COSMETICS SL | f564bbf0-3b5c-4a81-e053-2a95a90a7ea6 | 2023-08-29 | Warnings | ZF94AP8MEY |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Alembic Pharmaceuticals Limited | b6935240-ee81-49ef-adad-fb900d7f5127 | 2023-01-27 | Warnings, Adverse reactions | 3D867NP06J |
| Pramipexole dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Dr. Reddy's Laboratories Limited | 00699692-532a-68fd-8a51-3770a81b2208 | 2021-08-31 | Warnings, Adverse reactions | 3D867NP06J |
| Pramipexole Dihydrochloride Extended-Release | PRAMIPEXOLE DIHYDROCHLORIDE | Xiamen LP Pharmaceutical Co., Ltd. | 1cbd8ddf-4fc1-4cd0-906d-a55a4b8b1c3c | 2021-06-16 | Warnings, Adverse reactions | 3D867NP06J |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Alembic Pharmaceuticals Limited | 92f6ef1e-3256-45a7-a409-80dd85e95187 | 2017-11-20 | Warnings, Adverse reactions | 3D867NP06J |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | 2KR89I4H1Y |
| PRAMIPEXOLE | PRAMIPEXOLE | Camber Pharmaceuticals, Inc. | a7405a56-de1c-4875-b57f-210c991474ba | 2016-10-13 | Warnings, Adverse reactions | 3D867NP06J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.